Catherine Henry is named as a 2023 Siebel Scholar!

The Siebel Scholars Foundation announced the recipients of the 2023 Siebel Scholars award. Our very own Catherine Henry is a worthy recipient!

Now in its 22nd year, the Siebel Scholars program annually recognizes nearly 100 exceptional students commitment to academics and influencing future society. http://ow.ly/jC2f50KQAmM

Congratulations to Catherine and her talented scholar cohort!



New manuscript in Science - drug delivery, screening, cell biology, and machine learning combined to understand how different cancer cells respond to various nanoparticle formulations

Our collaborative work with the Hammond Lab and the Broad Institute around NanoPRISM was recently published in Science and covered in MIT News:

https://news.mit.edu/2022/how-different-cancer-cells-respond-drug-delivering-nanoparticles-0721

Congratulations to Dr. Rob Wilson!

The lab is very proud to announce the successful defense of Rob Wilson, the master of RNA binding proteins. Rob made strong contributions to our strategies to perturb MYC-driven transcription, including work focused on altering MYC transcripts using a variety of strategies (e.g. targeting MAX, LIN28B). He also pioneered a strategy to survey the target tractability of RNA-binding domains, generating new chemical matter for modulating previously intractable targets and staring down and understudied set of targets. Rob is scholar of high standards and his thoughtful criticism will be missed when he heads off to the real world.

Congrats to Morgan on her new Koch Institute Ludwig Center Postdoctoral Fellowship!

Morgan Stilgenbauer is the recipient of a 2022 Koch Institute Postdoctoral Fellowship, supported by the Ludwig Center at MIT. The fellowship supports her research into novel strategies to modulate the stability of oncogenic transcription factors by directly targeting proteins that regulate stability, such as chaperones or E# ligases, with lead-like or low molecular weight small molecules. Congrats from the team!

Congrats to Maddy on being named a 2021-2022 Convergence Scholar

The Marble Center for Cancer Nanomedicine and the MIT Center for Precision Cancer Medicine are pleased to announce the 2021-2022 class of Convergence Scholars. The Convergence Scholars Program (CSP) fosters the development of a new type of scientist—one who understands a broad range of disciplinary approaches, is able to ask creative questions, and is trained to answer those questions with diverse tools. By preparing postdocs for life beyond the bench, the CSP helps young scientists hone the skills they need to succeed within and beyond the academic setting. Read more at the Ki website.